IRCT201105236568N1已完成2 期
Effects of topical interferon Gamma 1b in the treatment of uveitic cystoid macular edema
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •(to have medial, posterior or pan-uveitis at least 3 months before the participation in the study together with macular cystoid edema secondary to uveitis in at least one eye; to have visual acuity equal or greater than 20/200; to be 18 to 60 year-old; to have a central macular thickness greater than 250 micrometers)
- •Exclusion criteria: (pregnancy or breast feeding; occurrence of intolerable adverse effects; to have a history of herpetic kerititis and multiple sclerosis; to have an active infection which needs an urgent treatment; history of chronic or recurrent infections)
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Clinical trial for evaluation of the effect of topical interferon a2b as a complementary treatment of macular edema of patients with diabetic retinopathy compared with placebodiabetic retinopathy.Diabetic retinopathyIRCT2016081529370N1Vice chancellor for research of Shiraz University of Medical Sciences50
已完成
2 期
The efficacy of topical interferon alpha-2b in pterygiumpterygium.Pterygium of eyeH11.0IRCT20190806044463N1Bagheiat-allah University of Medical Sciences18
进行中（未招募）
不适用
A phase II study about interferon gamma 1b to therapy the steroid-refractory bronchiolitis obliterans after allogenic stem cell therapysteroid-refractory bronchiolitis obliteransMedDRA version: 13.1Level: PTClassification code 10029888Term: Obliterative bronchiolitisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-022467-36-DEFreistaat Bayern
招募中
3 期
Efficacy and safety of Interferon beta-1-a in mild to moderate COVID-19IRCT20120703010178N25Shahid Beheshti University of Medical Sciences100
招募中
3 期
ReciGen for treatment of Covid-19Covid 19.COVID-19, virus identifiedU07.1IRCT20150914024017N1Tehran University of Medical Sciences40